Telithromycin – Presentation Agenda

Introduction Mindell Seidlin, MD

VP, Clinical Development,  Anti-Infectives, Aventis

Microbiology André Bryskier, MD

Human Pharmacology Vijay Bhargava, PhD

Clinical Efficacy and Safety Bruno Leroy, MD

ECG Analysis Claude Benedict, MD

Conclusions Mindell Seidlin, MD

Previous slide

Next slide

Back to first slide

View graphic version